pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma
Chinese Academy of
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chinese Academy of clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- China, TAIZHOU, CN
- Employees
- 170
- Programs
- 24
- Drugs
- 538
- Patents
- 4
Chinese Academy of projects
6 ClinicalTrials.gov programs sponsored by Chinese Academy of.
Chinese Academy of has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Cytarabine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML
3 trials -
Inactivated Poliomyelitis Vaccine (Sabin strains)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Poliomyelitis
2 trials -
Venetoclax
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML
2 trials -
a compound glutamine capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mucositis
1 trial -
a compound glutamine capsule/a compound glutamine capsule simulated placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mucositis
1 trial -
poliovirus vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Poliomyelitis
1 trial
Frequently asked questions
How many clinical projects does Chinese Academy of have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.